Mosaic and non-mosaic protocadherin 19 mutation leads to neuronal hyperexcitability in zebrafish
Open Access
- 20 April 2022
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 169, 105738
Abstract
No abstract availableKeywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatmentNature Communications, 2013
- Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor versus Electrographic Responses to Antiepileptic DrugsPLOS ONE, 2013
- A Novel PCDH19 Mutation Inherited From an Unaffected MotherPediatric Neurology, 2012
- Measuring thigmotaxis in larval zebrafishBehavioural Brain Research, 2012
- Differential expression, alternative splicing, and adhesive properties of the zebrafish δ1-protocadherinsNeuroscience, 2011
- Spontaneous Seizures and Altered Gene Expression in GABA Signaling Pathways in amind bombMutant ZebrafishJournal of Neuroscience, 2010
- Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects FemalesPLOS Genetics, 2009
- X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentNature Genetics, 2008
- Comparative Genomics and Diversifying Selection of the Clustered Vertebrate Protocadherin GenesGenetics, 2005
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995